Necrolytic migratory erythema-like eruption associated with erlotinib in a patient with lung adenocarcinoma
Author:
Funder
Ministry of Science and Technology
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference6 articles.
1. Skin manifestations of gefitinib and the association with survival of advanced non-small-cell lung cancer in Taiwan;Wang;Dermatol. Sin.,2011
2. Glucagonoma syndrome: a review and update on treatment;John;J. Eur. Acad. Dermatol. Venereol.,2016
3. Necrolytic migratory erythema-like skin lesion during gefitinib treatment: a rare cutaneous adverse reaction;Seong;JAMA Dermatol.,2016
4. Necrolytic migratory erythema (glucagenoma)-like skin lesions induced by EGF-receptor inhibition;Trojan;Swiss Med.,2003
5. Small-cell lung cancer and necrolytic migratory erythema;Mignogna;N. Engl. J. Med.,2008
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Consensus of the Taiwanese dermatological association and Taiwan Lung Cancer Society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experience;Journal of the Formosan Medical Association;2024-08
2. Zinc supplements may prevent and treat cutaneous toxicities induced by epidermal growth factor receptor inhibitors;Journal of the European Academy of Dermatology and Venereology;2023-01-14
3. Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma;Journal of the European Academy of Dermatology and Venereology;2022-11-16
4. Necrolytic migratory erythema-like eruptions induced by zinc deficiency during osimertinib treatment of EGFR-mutant non-small cell lung cancer: A case report;Current Problems in Cancer: Case Reports;2021-12
5. Erlotinib;Reactions Weekly;2020-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3